Trends in Biochemical Sciences
Restraining PI3K: mTOR signalling goes back to the membrane
Section snippets
Insulin–PI3K signalling activates mTOR signalling
PtdIns(3,4,5)P3 generated in the membrane by PI3K recruits members of intracellular signalling pathways containing pleckstrin homology (PH) domains to the plasma membrane, thereby coupling PI3K signals to downstream effector molecules [1]. Activation of one particular effector, protein kinase B (PKB; also known as AKT), seems to be essential not only in mediating the effects of insulin on glucose homeostasis, but also in regulating the profound effects of insulin and IGFs on mTOR signalling and
Targeting the IRS family of adaptors inhibits PI3K
Previous work on activation of PI3K by insulin indicates that negative regulation of PI3K occurs mainly at the level of the proximal tyrosine kinase substrates of the insulin receptor (InR) RTK – namely, the IRS proteins, a family of adaptor proteins that are essential both for PI3K activation and for mediating the pleiotropic effects of insulin 3, 21, 22.
In a pioneering study, Haruta et al. [23] showed that prolonged exposure to insulin leads to a decrease in both the electrophoretic mobility
Serine/threonine phosphorylation and IRS protein function
The idea that the decrease in mobility of IRS-1 resulting from chronic insulin stimulation is at least contributed to by an increase in phosphorylation now seems to be in little doubt. Thus, the decrease in IRS-1 electrophoretic mobility after chronic insulin stimulation is reversed by dephosphorylation with alkaline phosphatase treatment [30] and mimicked by okadaic acid, a protein phosphatase 2A (PP2A) serine/threonine phosphatase inhibitor 28, 31. An increase in serine/threonine
A role for mTOR signalling in PI3K inhibition
The rescuing effect of the mTOR inhibitor rapamycin in reversing the phosphorylation and inhibition of IRS-1 function resulting from prolonged insulin stimulation has suggested that a kinase (or kinases) that mediates mTOR signalling inhibits PI3K activation in addition to JNK and PKC.
mTOR is a component of two distinct large protein complexes that each contain at least three components. One complex is rapamycin sensitive, includes the mTOR kinase itself, raptor 42, 43 and GβL [44], and is
TSC1–TSC2 promotes PI3K activation by inhibiting mTOR signalling
The negative feedback inhibition of PI3K has been most frequently observed in normal cells after prolonged stimulation with insulin. Two early reports intriguingly indicated, however, that cells lacking the TSC1–TSC2 tumour suppressor also fail to activate PKB in response to insulin, suggesting that a similar mechanism might be used to inhibit PI3K activation caused by constitutive mTOR-dependent signalling 48, 49. New studies have helped to clarify the mechanisms involved in this inhibitory
mTOR signalling inhibits IRS transcription
Unlike previous work indicating that mTOR signalling affects only IRS phosphorylation and protein turnover, the studies of Shah et al. [51] and Harrington et al. [50] have surprisingly indicated that TSC1–TSC2 deficiency and the resulting activation of the mTOR pathway lead to a reduction in IRS-1 transcription (Figure 2). A microarray screen [50], confirmed by northern blot analysis 50, 51, revealed that the level of IRS-1 mRNA is reduced in TSC2-deficient cells as compared with
S6K and IRS-1 phosphorylation
The possibility that S6K might be the crucial rapamycin-sensitive effector responsible for directly phosphorylating IRS-1 and thereby inhibiting PI3K activation was first suggested by Tremblay and Marette [29] and has been subsequently investigated by Harrington et al. [50]. A specific serine residue in IRS-1, Ser302, has been shown to be phosphoryated by S6K in vitro [50] (Figure 1). Furthermore, phosphorylation of Ser302 in IRS-1 increases in the absence of TSC1–TSC2 function and is inhibited
Role of negative feedback regulation of PI3K in vivo
The physiological importance of negative feedback from mTOR and S6K to PI3K has been recently given impetus by a new study of S6K1-deficient mice [58]. This study suggests that at least some of the effects of a high-fat diet (HFD) on inhibiting the insulin–PI3K signalling pathway [59] might be mediated by S6K1 activation; thus, S6K1 is emerging as an attractive new therapeutic target in type 2 diabetes.
In an earlier study, S6K1-deficient mice were shown to be hypoinsulinaemic and mildly glucose
Concluding remarks
In this review, we have focused mainly on the role of mTOR signalling in mediating negative feedback on insulin–PI3K signalling and on the principal role of IRS-1 proteins as recipients of negative regulation from kinases such as S6K, which are normally regulated by nutrient–mTOR and PI3K signalling (Figure 3). Through this type of negative feedback regulation, PI3K and the production of PtdIns(3,4,5)P3 are selectively uncoupled from the stimulatory effects of insulin; this raises the obvious
Acknowledgements
We apologise to those whose work could not be cited owing to space limitations. We thank Brendan Manning, Jameel Shah and George Thomas for sharing data before publication. L.S.H. is supported by the Tuberous Sclerosis Association (UK), R.F.L. is supported by grants from Cancer Research UK and G.M.F. is funded by a studentship from the Institute of Cancer Research.
References (80)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway
Mol. Cell
(2002)Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb
Curr. Biol.
(2003)Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
Mol. Cell
(2003)TSC2 mediates cellular energy response to control cell growth and survival
Cell
(2003)Rapamycin partially prevents insulin resistance induced by chronic insulin treatment
Biochem. Biophys. Res. Commun.
(2002)Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells
J. Biol. Chem.
(2003)Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation
J. Biol. Chem.
(2003)- et al.
Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells
J. Biol. Chem.
(2001) The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307
J. Biol. Chem.
(2000)A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation
J. Biol. Chem.
(1997)
Insulin resistance: a phosphorylation-based uncoupling of insulin signaling
Trends Cell Biol.
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action
J. Biol. Chem.
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade
J. Biol. Chem.
Protein kinase C-ζ phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin
J. Biol. Chem.
Protein kinase C-ζ-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1
J. Biol. Chem.
Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes
J. Biol. Chem.
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation
Biochem. Biophys. Res. Commun.
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
Cell
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
Cell
GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR
Mol. Cell
Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism
J. Biol. Chem.
Inappropriate activation of the TSC1–TSC2/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies
Curr. Biol.
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302
J. Biol. Chem.
Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling
J. Biol. Chem.
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle
J. Biol. Chem.
Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin
J. Biol. Chem.
Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver
J. Biol. Chem.
Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex
J. Biol. Chem.
Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex
J. Biol. Chem.
Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2
J. Biol. Chem.
5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside
J. Biol. Chem.
PKCθ inhibits insulin signaling by phosphorylating IRS1 at Ser1101
J. Biol. Chem.
Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase
J. Biol. Chem.
Insulin stimulates PKCζ-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins
J. Biol. Chem.
Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer
Annu. Rev. Cell Dev. Biol.
The phosphoinositide 3-kinase pathway
Science
Insulin signaling in health and disease
Science
PI3K/Akt signalling pathway and cancer
Cancer Treat. Rev.
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene
Genes Dev.
Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB
Nat. Cell Biol.
Cited by (326)
Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation
2023, Journal of Biological ChemistryIntervertebral disc cell fate during aging and degeneration: apoptosis, senescence, and autophagy
2023, North American Spine Society JournalInsulin activates LC-PUFA biosynthesis of hepatocytes by regulating the PI3K/Akt/mTOR/Srebp1 pathway in teleost Siganus canaliculatus
2022, Comparative Biochemistry and Physiology Part - B: Biochemistry and Molecular Biology